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1. Introduction 
Both artificial and naturally occurring antioxidants have been reported to play major roles in 
protecting membranes and tissues from free radical and xenobiotic-induced oxidative 
damage (Burton, 1989; Carini et al., 1990). Most living organisms harbour both enzymatic 
and non-enzymatic systems that protect them against excessive reactive oxygen species. 
However, various external factors (smoke, diet, alcohol and some drugs) and aging decrease 
the efficiency of these protective systems, thereby disrupting the redox equilibrium that is 
established under healthy conditions. Thus, antioxidants that scavenge reactive oxygen 
species may be of great value in preventing the onset and propagation of oxidative diseases 
(Willet, 1994). Recently, more attention has been paid to the role of natural antioxidants, 
mainly phenolic compounds, which may have higher antioxidant activity than do 
conventional antioxidants, such as vitamins C, E and ȕ-carotene (Vinson et al., 1995). The 
anti-oxidative effects of natural phenolic compounds, in pure form or in extracts from 
various plant sources (vegetables, fruits and medicinal plants), have been studied in vitro 
using a variety of model systems (Meyer et al., 1998; Pietta et al., 1998; Yen & Hsieh, 1998). 
Therefore, antioxidants, which can neutralize free radicals, may be of central importance in 
the prevention of carcinogenicity, cardiovascular disease and neurodegenerative changes 
associated with aging (Halliwell, 1994; Yu, 1994). Epidemiological studies have shown that 
the consumption of vegetables and fruits can protect humans against oxidative damage by 
inhibiting and/or quenching free radicals and reactive oxygen species (Ames et al., 1993).  
Oxidative stress occurs commonly in living organisms, and it is involved in the pathology of 
cancer, arteriosclerosis, malaria, and rheumatoid arthritis. Moreover, it may play a role in 
neurodegenerative diseases and ageing processes. It has been demonstrated that many 
vegetables, fruits, medicinal plants and other foods contain compounds with bioactivity 
against oxidative stress, and this activity has been attributed to vitamin C, vitamin E, α-
tocopherol, ȕ-carotene, and polyphenolic compounds (Krishnaiah et al., 2011; Moure et al., 
2001). Therefore, research regarding natural antioxidants from foods and plants, particularly 
from folk medicinal plants, is receiving increasing attention throughout the world.  
2. Morinda citrifolia L.  
The ancestors of the Polynesians are believed to have brought many plants with them, as 
food and medicine, when they migrated from Southeast Asia 2000 years ago. Of the 12 most 
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common medicinal plants they brought, Morinda citrifolia L. was the second most popular 
plant used in herbal remedies to treat various common diseases and to maintain overall 
good health. Other names of Morinda citrifolia L. include M. bracteata Roxb.; M. litoralis 
Blanco; Indian mulberry, Bengkudu, Mengkudu (Malay). It has been reported to have a 
broad range of health benefits for subjects with cancer, infections, arthritis, diabetes, asthma, 
hypertension and pain. The Polynesians utilised the whole Morinda citrifolia L. plant in their 
medicinal remedies and as a dye for some traditional clothing. The roots, stems, bark, 
leaves, flowers, and fruits of the Morinda citrifolia L.  plant are all involved in various 
combinations in almost 40 known and recorded herbal remedies. Additionally, the roots 
were used to produce a yellow or red dye for tapa cloth and fala (mats), and the fruit was 
eaten for health and nutrition. There are numerous Polynesian stories of heroes and 
heroines that used Morinda citrifolia L. to survive famine. Morinda citrifolia has a long history 
of use as a food in tropical regions throughout the world. 
It has also been reported to have broad therapeutic effects, including anti-cancer activity, in 
both humans and laboratory animal models. However, the mechanisms underlying these 
effects remain unknown. M. citrifolia is unique in view of the large number of medicinal 
claims that have been made for its efficacy and its rapidly evolving commercial success; 
nevertheless, little is known about its pharmacological potential compared with other 
popularly used botanicals. 
M. citrifolia L., a shrub originating in tropical Asia or Polynesia, has been extensively used in 
folk medicine and as a dye in Asian countries. In the tropics, it seems to have been greatly 
valued medicinally, and the plant is normally cultivated for its roots, leaves and fruits. M. 
citrifolia, which grows prevalently in tropical regions, has recently gained a great deal of 
interest from scientists and medical professionals due to its pharmaceutical value. Wang et 
al. (2002) have published a review of M. citrifolia L.  research that summarises the 
therapeutic effects of various compounds in this plant. 
The M. citrifolia L. plant is a small evergreen tree found growing in open coastal regions at 
sea level and in forest areas up to approximately 1300 feet above sea level. The plant is often 
found growing along lava flows. Polynesians are reported to have successfully used M. 
citrifolia L. to treat breast cancer and eye problems. M. citrifolia has been tested for a number 
of biological activities in animal and anti-microbial studies and found that the dried fruit 
has smooth muscle stimulatory activity and histaminergic effects.  
The roots of these plants are reported to be good sources of anthraquinones, which are 
usually present as aglycones and, to lesser extent, in the form of glycosides (Thomson, 1971; 
Zenk, El-Shagy & Schulte, 1975). Most parts of the tree have been widely used medicinally 
to relieve rheumatism and other pains and for their healing effects (Perry & Metzger, 1980).  
Traditionally, the roots of M. citrifolia L. plants were used by Polynesians to produce yellow 
or red dye, but more importantly, they are now known to contain medicinally active 
components, such as anthraquinones, which due to their anti-oxidative activity, possess 
various therapeutic properties. These properties include anti-bacterial, anti-viral, and anti-
cancer activities, as well as analgesic effects. These factors make the compounds potentially 
useful in several medical applications. An increasing number of studies are focusing on 
finding efficient methods for producing and extracting anthraquinones from these plants. 
Much of the literature also involves producing the compound in root cultures of M. citrifolia. 
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Nevertheless, extraction of anthraquinones directly from plant roots is still more widely 
conducted and is conventionally performed by solvent extraction. Other techniques, which 
include super critical carbon dioxide extraction, subcritical water extraction, ultrasonic-
assisted extraction (UAE), and microwave-assisted extraction (MAE) have also become of 
interest as alternatives to the conventional methods.  
2.1 Plant description  
The genus Morinda (Rubiaceae), which includes the species M. Citrifolia L., is made up of 
around 80 species. M. Citrifolia is a bush or small tree, 3-10 m tall, with abundant broad 
elliptical leaves (5-17 cm length, 10-40 cm width).  
 
Fig. 1. Unripe fruit 
The small tubular white flowers are grouped together and inserted on the peduncle. The 
petioles leave ring-like marks on the stalks and the corolla is greenish-white (Morton, 1992; 
Elkins, 1998; Dixon et al., 1999; Ross, 2001; Cardon, 2003). The M. citrifolia L. fruit (3-10 cm 
length, 3-6 cm width) is ovular and fleshy with an embossed appearance (Fig. 1). It is 
slightly wrinkly, semi-translucent, and ranges in colour from green to yellow to almost 
white at the time of picking. It is covered with small reddish-brown buds containing the 
seeds. The ripe fruit emits a strong butyric acid-like, rancid smell (Morton, 1992; Dixon et al., 
1999). The pulp is juicy and bitter, a light dull yellow or whitish colour, and gelatinous 
when the fruit is ripe; numerous hard triangular reddish-brown pits are found, each 
containing four seeds (approximately 3.5 mm) (Dittmar, 1993).  
Moreover, M. citrifolia L. leaves are well known for their strong antioxidant activity, and 
they have been shown to be safe in acute, subacute, and subchronic oral toxicity tests on 
mice (West et al., 2007). Inspired by ancient Polynesian legends, M. citrifolia L. leaves have 
been developed into therapeutic teas. The leaves are also the source for a variety of other 
health-promoting commercial products. Commercial M. citrifolia L. leaf products have been 
available in Japan and United States for more than seven years, used mainly for making 
infusions. However, some manufacturers produce capsules containing powdered M. 
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citrifolia L. leaves. The major world-wide source of M. citrifolia L. leaves is French Polynesia 
because leaves from this nation having undergone a safety evaluation (West et al., 2007). 
Other sources include Panama, Fiji and Hawaii.  
Recently, M. citrifolia L. fruit juice is in high demand as an alternative medicine due to its 
potential anti-microbial, anti-cancer, anti-inflammatory, and antioxidant effects (Wang et al., 
2002). However, scientific evidence for the benefits of M. citrifolia L. fruit juice is still limited. 
In the past decade, M. citrifolia L. fruit juice has emerged on the worldwide market as a safe 
and popular health product due to its phytochemicals and nutrients. Written documentation 
of the consumption of this fruit as a food source precedes the twentieth century. Captain 
James Cook of the British Navy noted in the late 1700s that the fruit was eaten in Tahiti. An 
1866 publication in London explained that M. citrifolia L. fruit was consumed as a food in the 
Fiji islands.  
Later publications describe the use of this fruit as a food throughout the Pacific islands, 
Southeast Asia, Australia, and India. In Roratonga, “the fruit was often eaten by the 
natives". Australian Aborigines were reported to be “very fond” of the fruit. In Samoa, M. 
citrifolia L. fruit was common fare, and in Burma, the fruit was cooked in curries or eaten 
raw with salt. In 1943, Merrill described M. citrifolia L. as an edible plant in a technical 
manual of edible and poisonous plants of the Pacific islands, in which the leaves and fruits 
could be used as emergency food. Abbott also reported that M. citrifolia L. had been used as 
a food, drink, medicine, and colourful dye. The medicinal history and accumulated scientific 
studies have revealed and confirmed the Polynesians’ claims regarding the health benefits 
of M. citrifolia L.  
M. citrifolia L. has identifiable leaves, white tubular flowers, and a distinctive, ovoid, 
“grenade-like” yellow fruit. The fruit can grow in size up to 12 cm or more and has a lumpy 
surface covered by polygonal-shaped sections. The seeds, which are triangular and reddish 
brown, have an air sac contained at one end, making the seeds buoyant. This could explain, 
in part, the wide distribution of the plant throughout the Polynesian islands. The mature M. 
citrifolia L .fruit has a foul taste and odour. M. citrifolia L. is not considered to be at risk in the 
wild. 
The fruit juice of M. citrifolia L. is in high demand in alternative medicine for various 
illnesses, such as arthritis, diabetes, high blood pressure, muscle aches and pains, menstrual 
difficulties, headaches, heart disease, Acquired Immune Deficiency Syndrome (AIDS), 
cancer, gastric ulcers, sprains, mental depression, senility, poor digestion, atherosclerosis, 
blood vessel problems and drug addiction (Kamiya et al., 2004; Wang et al., 2002). Therefore, 
one of the challenges in recent years has been to process fruit juice so as to make a more 
modern drug from a traditional product (Chunhieng et al., 2003). A number of in vitro 
biological activities have been reported, such as angiogenesis inhibition, antioxidant activity, 
inhibition of cycloxygenases-1 and -2, and tyrosine kinase inhibition. However, most of 
these have only been tested with crude extracts or fractions of M. citrifolia L., and the 
compound(s) responsible for these biological activities have not been fully determined, 
except for two compounds, neolignan and americanin A, which were identified in an n-
butanol-soluble partition of the methanol extract of M. citrifolia L. fruits (Su et al., 2005; Zin 
et al., 2002).  
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M. citrifolia L. has recently been the object of many claims concerning its nutraceutical 
properties. Various publications have shown that M. citrifolia L. can be used to relieve 
multiple diseases, and its registered uses span the Pacific, Asia, and Africa. Two clinical 
studies have reported that relief from arthritis and diabetes are associated with M. citrifolia 
L. consumption (Elkins, 1998; Solomon, 1999). These beneficial effects may derive from 
certain compounds, such as scopoletin, nitric oxide, alkaloids and/or sterols, and they also 
may be due to the antioxidant potential of M. citrifolia L. As a result of this reputation, 
consumption of this fruit is currently high not only in the producing countries but also in 
the United States, Japan and Europe.  
In response to this demand, some countries (such as Costa Rica and Cambodia) have 
increased their cultivation of M. citrifolia L. In these countries, the fruit is often 
commercialised fresh or as juice in both formal and informal markets, but it is also found as 
pasteurised juice, either in pure form or in combination with other juices (usually grape or 
blackberry juice). Commercial interest in M. citrifolia L. has increased tremendously in recent 
years, as indicated by the number of patents registered. In the United States alone, 19 
patents have been registered by the US patent and Trademark Office since 1976 (USPTO, 
2005). M. citrifolia L. juice has been accepted by the European Union as a novel food 
(European Commission, Scientific Committee for Food, 2002). Nevertheless, despite the real 
market opportunities, there has been little scientific research addressing the actual 
nutritional and functional properties of M. citrifolia L. products. 
Several classes of compounds have been isolated from M. citrifolia L., including amino acids, 
anthraquinones, coumarins, fatty acids, flavonoids, iridoids, lignans and polysaccharides 
(Chan-Blan-co et al., 2006). Among these, scopoletin, a coumarin derivative, is one of the 
representative ingredients in M. citrifolia L. Its contribution to anti-microbial, anti-
inflammatory, and antioxidative activities has been well elucidated (Deng et al., 2007). 
Samoylenko et al. (2006) recommended scopoletin as a constituent marker for M. citrifolia L. 
quality control. This compound has been ubiquitously found in M. citrifolia L. collected from 
Atlantic and Pacific regions and in all examined squeezed fruit juices. Determination of 
scopoletin in M. citrifolia L. might help to control the quality of M. citrifolia L. products. 
However, no reports have evaluated the antioxidative activity of scopoletin and other 
coumarin derivatives in M. citrifolia L.  
Many reports on the antioxidative activity of M. citrifolia L. itself have been published. 
Assays of free-radical-scavenging activity with 1,1-diphenyl-2-picrylhydrazyl (Su et al., 
2005; Yang et al., 2007), inhibition of copper-induced low-density lipoprotein oxidation 
(Kamiya et al., 2004), nitric oxide scavenging activity (Basu & Hazra, 2006) and quenching of 
H2O2 (Chong et al., 2004; Jeffers et al., 2007) have been performed to evaluate the 
antioxidative effects of M. citrifolia L. and its products. Polyphenols, reducing glycosides 
(Calzuola et al., 2006), lignin derivatives (Su et al., 2005) and anthraquinones (Chong et al., 
2004) have been suggested as sources of antioxidative activity in M. citrifolia L. However, 
there is little available information with which to quantitatively evaluate the antioxidative 
activity of M. citrifolia L ingredients. Recently, a correlation between total phenol and free-
radical-scavenging activity was reported (r=0.41, Yang et al., 2007).  
The chemical components of M. citrifolia L. have not been well studied, and several 
anthraquinones and asperuloside are all that have been previously isolated (Levand & 
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Larson, 1979; Srivastava & Singh, 1993). For centuries, scientists and medical professionals 
have been investigating the chemical constituents in all parts of M. citrifolia (Noni or Yor), 
including leaves, fruit, bark and roots. The plants contain several medicinally active 
components that exhibit various therapeutic effects. These include anti-bacterial, anti-viral 
and anti-cancer activities as well as analgesic effects. Critical reviews of the therapeutic 
properties of the plants are given by Chan-Blanco et al. (2006) and Wang et al. (2002). 
Anthraquinones have been shown to be responsible for the therapeutic properties of M. 
citrifolia L., and among this group of compounds, damnacanthal, which is present mainly in 
the roots, is of particular interest due to its important anticancer activity (Hiramatsu et al., 
1993).  
Previous phytochemical studies revealed that M. citrifolia L. leaves contain a variety of 
phytochemical constituents, including terpenoids (Ahmad & Bano, 1980; Saludes et al., 2002; 
Takashima et al., 2007) phytosterols, fatty acids and their glycosides (Takashima et al., 2007) 
iridoids and their glycosides (Sang et al., 2001 a,b,c,d; Sang et al., 2003) and flavonol 
glycosides (Sang et al., 2001a).  
Flavonol glycosides appear to predominate in M. citrifolia L. leaves; rutin and other flavonol 
glycosides have previously been identified in raw M. citrifolia L. leaves (Sang et al., 2001a). 
However, the presence of flavonol aglycones in M. citrifolia L. leaves has not been previously 
reported. Flavonoids have been indicated to possess a variety of biological activities (Garcia-
Mediavilla et al., 2006; Kampkotter et al., 2007), and they may play an important role in M. 
citrifolia L. leaves. To date, there has been no validated analytical method for determining 
the flavonol constituents of M. citrifolia L. leaves. 
2.2 Yield 
M. citrifolia L. is a perennial bush, and it is possible to find fruits at different stages 
of maturity on the same plant at the same time. The species is generally found from 
sea level to 400 m, although it adapts better to coastal regions (Luberck & Hannes, 
2001). Under favourable conditions, the plant bears fruit approximately nine months 
to one year after planting. At this stage, the fruits can be harvested, but they are generally 
small, and the yield per tree is low. Some producers choose not to harvest in the first 
year, and they prune in order to let the bush grow stronger. In Hawaii, M. citrifolia 
L. fruits are harvested throughout the year, although there are seasonal patterns in 
flowering and fruit bearing (meteorological factors, fumigation, and irrigation) (Nelson, 
2001, 2003).  
In Hawaii, M. citrifolia L. plots are usually harvested two or three times per month, although 
fruit production is lower during winter. With a density of 638 plants per hectare; good soil 
fertility, drainage, and irrigation; appropriate pest, disease and weed control; and an 
appropriate fertilisation plan, it is possible to obtain yields of 7 tonnes/ha/year after the 
fifth year (Nelson, 2001, 2003). With a juice extraction rate of approximately 50% (w/w), one 
hectare can thus yield around 35 tons of juice. However, many factors may affect these 
yields, and most producers do not obtain such good results because of diseases and/or poor 
agricultural practices (growing wide plants). In Hawaii, an average annual yield of 50 
tonnes/ha is generally attained (Nelson, 2001, 2003). 
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Maturity stage Colour Firmness 
1 Dark green  Very hard 
2 Green-yellow Very hard 
3 Pale yellow Very hard 
4 Pale yellow Fairly hard 
5 Translucent-greyish Soft 
Table 1. Evolution of fruit skin colour and firmness in the course of ripening (adapted from 
Chan-Blanco et al., 2006) 
Depending on the post-harvest technology programme adopted, the fruits may be harvested 
at different stages of development and continue to mature. The evolution of the colour and 
firmness of fruits left to ripen naturally on the tree is reported in Table 1. Nonetheless, most 
processors buy M. citrifolia L. harvested at the “hard white” stage for juice production as the 
fruits become soft too quickly once this stage is reached (Nelson, 2001, 2003). The change 
from stage 4 to 5 occurs very quickly (within a few hours), and the pulp practically liquefies 
and turns from green to white, as well as develops the characteristic butyric smell.  
The fruits are individually selected on the tree and harvested by hand. At the “hard white” 
stage, they are well able to withstand being transported in baskets or containers, and 
exposure of the fruits to light or high temperatures immediately after harvest does not affect 
their overall quality. Before processing, fruits are ripened at room temperature for one day 
or more, depending on the end product (such as tea, juice, pulp, dietetic products) (Nelson, 
2003).  
2.3 Chemical composition of M. citrifolia L. 
Approximately 160 phytochemical compounds have already been identified in the M. 
citrifolia L. plant, and the major micronutrients are phenolic compounds, organic acids and 
alkaloids (Wang & Su, 2001). Of the reported phenolic compounds, the most important are 
anthraquinones (such as damnacanthal, morindone, morindin.) and also aucubin, 
asperuloside, and scopoletin (Wang & Su, 2001). The main organic acids are caproic and 
caprylic acids (Dittmar, 1993), whereas the principal reported alkaloid is xeronine (Heinicke, 
1985). Chan-Blanco et al. (2006) reviewed the chemical constituents of different parts of the 
plant (Table 2). 
However, chemical composition differs significantly according to the part of the plant. The 
complete physico-chemical composition of the fruit has not yet been reported, and only 
partial information is available on M. citrifolia L. juice. The fruit contains 90% water, and the 
main components of the dry matter appear to be soluble solids, dietary fibre and proteins 
(Chunhieng, 2003). The fruit's protein content is surprisingly high, representing 11.3% of the 
juice dry matter, and the main amino acids are aspartic acid, glutamic acid and isoleucine 
(Chunhieng, 2003).  
According to a book on Malaysian medicinal plants, the chemical constituents of M. citrifolia L. 
are 5,7-Acacetin-7-O-┚-D(+)-glycopyranoside, ajmalicine isomers, alizarin, asperuloside, 
asperulosidic acid, chrysophanol (1,8-dihydroxy-3-methylanthraquinone), damnacanthol, 
digoxin, 5,6-dihydroxylucidin, 5,6-dihydroxylucidin-3-┚-primeveroside, 5,7-dimethylapigenin-
4’-O-┚-D(+)-galacto pyranoside, lucidin, lucidin-3-┚-primeveroside, 2-methyl-3,5,6-trihydroxy 
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Source (plant part) Chemical constituent References 
Flower 2-methyl-4-hydroxy-5,7-
dimethoxyanthraquinone 4-O-┚-D-
glucopyranosyl-(1-4)-┙-L-
rhamnopyranoside 
Sang et al. (2002) 
Flower 5,8-dimethyl-apigenin 4’-O-┚-D-
galacatopyranoside 
Sang et al. (2002), Elkins (1998) 
Flower Aracetin 7-O-┚-D-glucopyranoside  
Fruit ┚-D-glucopyranose pentaacetate Sang et al. (2002), Elkins (1998) 
Fruit 2,6-di-O-(┚-D-glucopyranosyl-1-O-
octanoyl-┚-D-glucopyranose 
Dittmar (1993) 
Fruit 6-O-(┚-D-glucopyranosyl-1-O-octanoyl-
┚-D-glucopyranose 
Wang et al. (1999) 
Fruit Ascorbic acid Liu et al. (2001) 
Fruit Asperulosidic acid Morton (1992), Elkins (1998), 
Wang et al. (2002), McClatchey 
(2002) 
Fruit Asperuloside tetraacetate Wang et al. (1999), Liu et al. 
(2001), Cardon (2003) 
Fruit Caproic acid Dittmar (1993) 
Fruit Caprylic acid Sang et al. (2002), Dittmar 
(1993), Elkins (1998), Wang et 
al. (2002), Levend and Larson 
(1979) 
Fruit Ethyl caprylate Solomon (1999), Dittmar 
(1993), Cardon (2003), Elkins 
(1998), Wang et al. (2002), 
Levand and Larson (1979) 
Fruit Ethyl caproate Dittmar (1993) 
Fruit Hexanoic acid Dittmar (1993) 
Fruit Octanoic acid Farine et al. (1996), Sang et al. 
(2002) 
Fruit Quercetin 3-O-┙-L-rhamnopyranosyl-
(1-6)-┚-D-glucopyranoside 
Farine et al. (1996), Sang et al. 
(2002), Cardon (2003), Wang & 
Su (2001) 
Heartwood Physcion 8-O-┙-L-arabinopyranosyl-(1-
3)-┚-D-galactopyranosyl-(1-6)-┚-D-
galactopyranoside 
Wang & Su (2001), Wang et al. 
(2002) 
Leaves Alanine Sang et al. (2002), Srivastava & 
Singh (1993), Cardon (2003) 
Leaves Quercetin 3-O-┙-L-rhamnopyranosyl-
(1-6)-┚-D-glucopyranoside 
Sang et al. (2002) 
Leaves Serine Dittmar (1993), Elkins (1998) 
Leaves Threonine Dittmar (1993), Elkins (1998) 
Leaves Tryptophan Dittmar (1993), Elkins (1998) 
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Source (plant part) Chemical constituent References 
Leaves Tyrosine Dittmar (1993), Elkins (1998) 
Leaves Ursolic acid Sang et al. (2002), Cardon 
(2003), Elkins (1998), Wang et 
al. (2002) 
Leaves Valine Dittmar (1993), Elkins (1998) 
Plant 2-methyl-3,5,6-
trihydroxyanthraquinone 
Cardon (2003), Inoue et al. 
(1981) 
Plant 2-methyl-3,5,6-
trihydroxyanthraquinone 6-O-┚-D-
xylopyranosyl-(1-6)-┚-D-
glucopyranoside 
Cardon (2003), Inoue et al. 
(1981) 
Plant 3-hydroxymorindone Cardon (2003), Inoue et al. 
(1981) 
Plant 3-hydroxymorindone 6-O-┚-D-
xylopyranosyl-(1-6)-┚-D-
glucopyranoside 
Cardon (2003), Inoue et al. 
(1981) 
Plant 5,6-dihydroxylucidin 3-O-┚-D-
xylopyranosyl-(1-6)-┚-D-
glucopyranoside 
Cardon (2003), Inoue et al. 
(1981) 
Plant 5,6-dihydroxylucidin Cardon (2003), Inoue et al. 
(1981) 
Plant Aucubin Elkins (1998), Wang et al. 
(2002) 
Plant Linoleic acid Wang et al. (2002) 
Plant Lucidin Cardon (2003), Inoue et al. 
(1981), Ross (2001) 
Plant Lucidin 3-O-┚-D-xylopyranosyl-(1-6)-┚-
D-glucopyranoside 
Cardon (2003), Inoue et al. 
(1981) 
Plant Scopoletin Farine et al. (1996), Wang et al. 
(2002) 
Leaves Arginine Dittmar (1993) 
Leaves Aspartic acid Dittmar (1993) 
Leaves ┚-sitosterol Sang et al. (2002), Chunhieng 
(2003), Elkins (1998), Wang et 
al. (2002) 
Leaves Citrifolinoside B Sang et al. (2002) 
Leaves Cysteine Dittmar (1993), Elkins (1998) 
Leaves Cystine Dittmar (1993), Elkins (1998) 
Leaves Glutamic acid Dittmar (1993) 
Leaves Glycine Dittmar (1993), Elkins (1998) 
Leaves Histidine Dittmar (1993), Elkins (1998) 
Leaves Isoleucine Dittmar (1993), Elkins (1998) 
Leaves Kaempferol 3-O-┙-L-rhamnopyranosyl-
(1-6)-┚-D-glucopyranoside 
Sang et al. (2002) 
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Source (plant part) Chemical constituent References 
Leaves Kaempferol 3-O-┚-D-glucopyranosyl-
(1-2)- ┙-L-rhamnopyranosyl-(1-6)-┚-D-
galactopyranoside 
Sang et al. (2002) 
Leaves Leucine Dittmar (1993), Elkins (1998) 
Leaves Methionine Dittmar (1993), Elkins (1998) 
Leaves Phenylalanine Dittmar (1993), Elkins (1998) 
Leaves Proline Dittmar (1993), Elkins (1998) 
Leaves Quercetin 3-O-┚-D-glucopyranoside Sang et al. (2002) 
Root, heartwood, 
root bark 
Morindone Sang et al. (2002), Inoue et al. 
(1981), Dittmar (1993), Ross 
(2001), Cardon (2003), Wang et 
al. (2002) 
Root, heartwood, 
seeds 
Damnacanthal Sang et al. (2002), Cardon 
(2003) 
Leaves Quercetin 3-O-┚-D-glucopyranosyl-(1-
2)- ┙-L-rhamnopyranosyl-(1-6)-┚-D-
galactopyranoside 
Sang et al. (2002) 
Root 8-hydroxy-8-methoxy-2-methyl-
anthraquinone 
Cardon (2003), Solomon (1999) 
Root Rubichloric acid Elkins (1998), Morton (1992) 
Root 1,3-dihydroxy-6-methyl anthraquinone Morton (1992) 
Root Morenone 1 Solomon (1999) 
Root Morenone 2 Solomon (1999) 
Root Ruberythric acid Cardon (2003) 
Root Rubiadin Cardon (2003), Elkins (1998), 
Inoue et al. (1981), Ross (2001) 
Root bark Chlororubin Dittmar (1993), Elkins (1998) 
Root bark Hexose Dittmar (1993) 
Root bark Morindadiol Dittmar (1993) 
Root bark Morindanidrine Dittmar (1993) 
Root bark Morindine Cardon (2003), Dittmar (1993), 
Elkins (1998), Morton (1992) 
Root bark Pentose Dittmar (1993) 
Root bark Physcion Solomon (1999) 
Root bark Rubiadin monomethyl ether Dittmar (1993) 
Root bark Soranjidiol Dittmar (1993), Elkins (1998), 
Ross (2001) 
Root bark Trioxymethylanthraquinone monoethyl 
ether 
Dittmar (1993) 
Root, root bark, 
fruit 
Alizarin Cardon (2003), Dittmar (1993), 
Elkins (1998), Ross (2001), 
Wang et al. (2002) 
Seeds Ricinoleic acid Solomon (1999) 
Table 2. Chemical compounds of M. citrifolia L. (adapted from Chan-Blanco et al., 2006) 
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anthraquinone, 3-hydroxymorindone, 3-hydroxymorindone-6-┚-primereroside, ┙-
methoxyalizarin, 2-methyl-3,5,6-trihydroxyanthraquinone-6-┚-primeveroside, 
monoethoxyrubiadin, morindadiol, morindin, morindone (1,5,6-trihydroxy-2-
methylanthraquinone), morindone-6-┚-primeveroside, nordamnacanthal, quinoline, 
rubiadin, rubiadin 1-methyl ether, saronjidiol, ursolic acid, alkaloids, anthraquinones and 
their glycosides, caproic acid, caprylic acid, fatty acids and alcohols (C5-9), flavone 
glycosides, flavonoids, glucose (┚-D-glucopyranose), indoles, purines, and ┚-sitosterol. 
Minerals account for 8.4% of the dry matter, and these minerals are mainly potassium, 
sulphur, calcium and phosphorus; traces of selenium have been reported in the juice 
(Chunhieng, 2003, Table 3). Vitamins have been reported in the fruit, mainly ascorbic acid 
(24-158 mg/100 g dry matter) (Morton, 1992; Shovie & Whistler, 2001) and provitamin A 
(Dixon et al., 1999). Phenolic compounds have been found to be the major group of 
functional micronutrients in M. citrifolia L. juice: damnacanthal, scopoletin, morindone, 
alizarin, aucubin, nordamnacanthal, rubiadin, rubiadin-1-methyl ether and other 
anthraquinone glycosides have been identified in M. citrifolia L. (Morton, 1992; Dittmar, 
1993; Dixon et al., 1999; Wang & Su, 2001). Damnacanthal is an anthraquinone that has been 
characterised and has some important functional properties (mainly anti-carcinogenic) 
(Solomon, 1999). Scopoletin is a coumarin that was isolated in 1993 at the University of 
Hawaii and has been found to have analgesic properties as well as a significant ability to 
control serotonin levels in the body (Levand & Larson, 1979). Other researchers have shown 
that scopoletin may also have anti-microbial (Duncan et al., 1998) and anti-hypertensive 
effects (Solomon, 1999).  
Multiple Hawaiian teams (Heinicke, 1985; Solomon, 1999) have reported the presence of a 
novel component, proxeronine, which is an alkaloid that is claimed to combine with human 
proteins and improve their functionality. The above authors attribute most of the beneficial 
effects of M. citrifolia L. to xeronine. Nonetheless, neither the chemical characterisation of 
this alkaloid nor the method used to assess its levels has been published to date.  
 
Characteristic Chunhieng (2003)a Shovic and Whistler 
(2001)a 
European 
commission (2002)b 
pH 3.72 - 3.4-3.6 
Dry matter 9.8±0.4% - 10-11% 
Total soluble solids (°Brix) 8 - - 
Protein content  2.5% 0.4 g/100 g 0.2-0.5% 
Lipids  0.15% 0.3 g/100 g 0.1-0.2% 
Glucose 11.9±0.2 g/l - 3-4 g/100  g 
Fructose 8.2±0.2 g/l - 3-4 g/100 g 
Potassium 3900 mg/l 188 mg/100 g 30-150 mg/100 g 
Sodium 214 mg/l 21 mg/100 g 15-40 mg/100 g 
Magnesium 14 mg/l 14.5 mg/100 g 3-12 mg/100 g 
Calcium 28 mg/l 41.7 mg/100 g 20-25 mg/100 g 
Vitamin C - 155 mg/100 g 3-25 mg/100 g 
Table 3. Physico-chemical composition of M. citrifolia L. juice (adapted from Chan-Blanco et 
al., 2006) 
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Approximately 51 volatile compounds have been identified in the ripe fruit (Sang et al., 
2001), including organic acids (mainly octanoic and hexanoic acids), alcohols (3-methyl-3-
butene-1-ol), esters (methyl octanoate, methyl decanoate), ketones (2-heptanone) and 
lactones ((E)-6-dodeceno-Ȗ-lactone) (Farine et al., 1996).  
Major components 
A number of major components have been identified in the M. citrifolia L. plant, such as 
scopoletin, octanoic acid, potassium, vitamin C, terpenoids, alkaloids, anthraquinones (such 
as nordamnacanthal, morindone, rubiadin, rubiadin-1-methyl ether and anthraquinone 
glycoside), ┚-sitosterol, carotene, vitamin A, flavones glycosides, linoleic acid, alizarin, 
amino acids, acubin, L-asperuloside, caproic acid, caprylic acid, ursolic acid, rutin and a 
putative proxeronine.  
A research group led by Chi-Tang Ho at Rutgers University in the United States (US) is 
searching for new novel compounds in the M. citrifolia L. plant. They have successfully 
identified several new flavonol glycosides, an iridoid glycoside from M. citrifolia L. leaves, a 
trisaccharide fatty acid ester, rutin, and an asperulosidic acid from the fruit. Two novel 
glycosides and a new unusual iridoid named citrifolinoside have been shown to have an 
inhibitory effect on AP-1 transactivation and cell transformation in the mouse epidermal JB6 
cell line. James Duke listed 23 different phytochemicals found in M. citrifolia L. as well as 5 
vitamins and 3 minerals in an authoritative handbook of phytochemicals. 
Xeronine system  
Retired biochemist Ralph Heinicke states that M. citrifolia L. fruit contains a natural 
precursor of xeronine that he named Proxeronine. Proxeronine is converted to the alkaloid 
xeronine in the body by an enzyme he named proxeroninase. His hypothesis is that xeronine 
is able to modify the molecular structure of proteins. Thus, xeronine has a wide range of 
biological activities. When a protein such as an enzyme, receptor, or signal transducer is not 
in the appropriate conformation, it will not work properly. Xeronine will interact with the 
protein and make it fold into its proper conformation. The result is a properly functioning 
protein. Whenever a problem arises in the cell due to a structural problem with a protein, 
xeronine’s presence would be beneficial. His hypothesis may explain why Tahitian Noni @ 
juice (TNJ) can help in many health problems in different ways. He has obtained several 
patents for xeronine. He states that the active ingredient in many of the effective folklore 
drugs is xeronine. This alkaloid is a critical normal metabolic coregulator. The ailments that 
he believes are helped by M. citrifolia L. include high blood pressure, menstrual cramps, 
arthritis, gastric ulcers, sprains, injuries, mental depression, senility, poor digestion, drug 
addiction, and pain. “I have devoted much of my life to the study of this unique substance 
that I have named ‘xeronine’. I am convinced of the tremendous benefits achieved by 
furnishing the body with a proper supply of this material” (Heinicke, 2001).  
2.4 Biological activity of M. Citrifolia L. 
2.4.1 Anti-microbial effects  
The anti-microbial activity of M. citrifolia L. may have been its first observed property; 
indeed, the fruit contains relatively large amounts of sugars that do not ferment even when 
fruits are stored in closed containers at ambient temperature. This property is used to 
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transport the fruit by boat from the scattered Pacific islands to processing plants without 
specific treatment.  
It has been reported that M. citrifolia L. inhibits the growth of certain bacteria, such as 
staphylococcus aureus, Pseudomonas aeruginosa, Proteus morgaii, Bacillus subtilis, 
Escherichia coli, Helicobacter pylori, Salmonella and Shigella (Atkinson, 1956). The same 
author claims that the anti-microbial effect observed may be due to the presence of phenolic 
compounds such as acubin, l-asperuloside, alizarin, scopoletin and other anthraquinones. 
Another study showed that an acetonitrile extract of the dried fruit inhibits the growth of 
Pseudomonas aeruginosa, Bacillus subtilis, Escherichia coli, and Streptococcus pyrogene 
(Locher et al., 1995).  
It has also been found that ethanol and hexane extracts of M. citrifolia L. have an 
antitubercular effect as they inhibit the growth of Mycobacterium tuberculosis by 89-95% 
(Saludes et al., 2002). The major components identified in the hexane extract are E-phytol, 
cycloartenol, stigmasterol, ȕ-sitosterol, campesta-5,7,22-trien-3-ȕ-ol, and the ketosteroids 
stigmasta-4-en-3-one and stigmasta-4-22-dien-3-one.  
Other studies have reported a significant antimicrobial effect on various strains of 
Salmonella, Shigella, and E. coli (Bushnell et al., 1950; Dittmar, 1993). Furthermore, they 
showed that the anti-microbial effect is highly dependent on the stage of ripeness and on 
processing, being greater when the fruit is ripe and undried.  
2.4.2 Anti-cancer activity  
The immunomodulatory properties (the capacity to enhance the host immune system) of M. 
citrifolia L. juice have been studied by a Japanese research team (Hirazumi et al., 1996; 
Hirazumi & Furusawa, 1999). The ethanol precipitable fraction (ppt) of M. citrifolia L. juice, 
corresponding to a polysaccharide-rich substance composed of glucuronoic acid, galactose, 
arabinose and rhamnose, has been found to have immunomodulatory and anti-tumour 
effects against Lewis lung carcinoma (LLC). In cell models, M. citrifolia L.-ppt seems to 
stimulate the production of T-cells, thymocytes and macrophages that produce cytokines, 
which are important mediators of tumour cytostasis and cytotoxicity.  
M. citrifolia L.-ppt also appears to stimulate murine effector cells to release several mediators 
such as cytokines. These mediators slow down the cell cycle in tumours, increase the 
response of cells to other immunised cells that fight tumour growth and have potent 
macrophage activator activity suspected of playing a role in the death of tumours (Hirazumi 
et al., 1996; Hirazumi & Furusawa, 1999).  
In the same study, mice were inoculated with LLC, and those ingesting a daily dose of 15 
mg of M. citrifolia L. juice showed a significant increase (119%) in lifespan. Nine out of 22 
mice with terminal cancer survived for more than 50 days. In addition, the ingestion of M. 
citrifolia L.-ppt combined with conventional chemotherapy proved to increase the lifespan of 
mice with cancer, (Hirazumi et al., 1994).  
Another Japanese team studied the influence of damnacanthal, an anthraquinone extracted 
from a chloroform extract of M. citrifolia L. fruits. Surprisingly, the researchers found that 
damnacanthal induces normal morphology in a particular type of cell found in human 
neoplasias (K-ras-NKR cells) that multiply uncontrollably and are highly malignant 
(Hiramatsu et al., 1993).  
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Another study showed that commercial M. citrifolia L. juice (Tahitian Noni juice) prevents 
the formation of chemical carcinogen-DNA-adducts. In the above study, rats with artificially 
induced cancer in specific organs were fed for one week with 10% M. citrifolia L. juice in 
their drinking water and rat food (rat chow) ad libitum. They showed reduced DNA-adduct 
formation depending on sex and organ. The reduction rates were: in female rats, heart 30%, 
liver 42%, lungs 41% and kidneys 80%; in male rats, heart 60%, liver 70%, lungs 50% and 
kidneys 90% (Wang & Su, 2001).  
2.4.3 Anti-oxidant properties  
The antioxidant properties of ethanol and ethyl acetate extracts of M. citrifolia L. fruit have 
been assessed using the ferric thiocyanate method (FTC) and thiobarbituric acid test (TBA). 
The authors found that ethyl acetate extract strong inhibited lipid oxidation, comparably to 
the same weight of pure α-tocopherol and butylated hydroxyl toluene (BHT) (Mohd et al., 
2001).  
Radical scavenging activity was also measured in vitro by the tetrazolium nitroblue (TNB) 
assay in commercial juice by assessing the capacity of the juice to protect cells and lipids 
from oxidative alteration promoted by superoxide anion radicals (SARs). The SAR 
scavenging activity of M. citrifolia L. juice was shown to be 2.8 times higher than that of 
vitamin C, 1.4 times that of pycnogenol (PYC) and almost the same magnitude as that of 
grape seed powder (Wang & Su, 2001).  
2.4.4 Anti-inflammatory activity  
The anti-inflammatory activity of an aqueous extract from M. citrifolia L.-juice was observed 
by inducing a locally acute inflammatory response with the help of a pro-inflammatory 
agent (bradykinin). It was found that the oral administration of M. citrifolia L. juice extract 
(200 mg) rapidly inhibits the formation of rat paw oedema. This effect may have resulted 
from interference with the B2 receptor-mediated mechanism by which bradykinin induces 
rat paw oedema (Mckoy et al., 2002).  
Another study showed that commercial M. citrifolia L. juice selectively inhibits cyclo-
oxygenase enzymes (COX-1 and COX-2) involved in breast, colon and lung cancer and also 
has anti-inflammatory activity (Su et al., 2001). The ability of noni juice to inhibit these 
enzymes was compared to that of traditional commercial non-steroidal inflammatory drugs, 
such as aspirin, Indomethacin and Celebrex. M. citrifolia L. juice showed selective inhibition 
of COX activity in vitro and a strong anti-inflammatory effect comparable to that of 
Celebrex, and presumably, this juice lacks side effects.  
2.4.5 Analgesic activity  
Recent research has examined the analgesic properties of commercial juice in rats. The 
results showed that rats fed 10% or 20% M. citrifolia L. juice had greater pain tolerance (162% 
or 212%, respectively) compared with the placebo group (Wang et al., 2002). A French 
research team has also studied the analgesic and sedative effects of M. citrifolia L. on mice 
through the writhing and hotplate tests. M. citrifolia L. root extract (1600 mg/kg) showed 
significant analgesic activity in the animals, similar to the effect of morphine (75% and 81% 
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protection using M. citrifolia L. extract and morphine, respectively), and it also proved to be 
non-toxic (Younos et al., 1990).  
2.4.6 Cardiovascular activity 
Recent research has demonstrated the ability of M. citrifolia L. fruit to prevent 
arteriosclerosis, a disease related to the oxidation of low density lipoproteins (LDLs). 
Methanol and ethyl acetate extracts showed 88% and 96% inhibition, respectively, of copper-
induced LDL oxidation by the thiobarbituric acid relative substance method. This beneficial 
effect could be due to the presence of lignans, which are phenylpropanoid dimers (Kamiya 
et al., 2004).  
2.5 Biological activities of M. citrifolia L. products  
2.5.1 Antibacterial activity  
Acubin, l-asperuloside, alizarin in M. citrifolia L. fruit, and certain other anthraquinone 
compounds in M. citrifolia L. roots, are all proven antibacterial agents. These compounds 
have been shown to fight infectious bacteria such as Pseudomonas aeruginosa, Proteus 
morgaii, Staphylococcus aureus, Bacillis subtilis, Escherichia coli, Salmonella, and Shigela. 
These antibacterial compounds in M. citrifolia L. are responsible for the treatment of skin 
infections, colds, fevers, and other bacteria-caused health problems. Bushnell reported on 
the antibacterial properties of certain plants found in Hawaii, including M. citrifolia L. He 
further reported that M. citrifolia L. was traditionally used to treat broken bones, deep cuts, 
bruises, sores and wounds. Extracts from the ripe M. citrifolia L. fruit exhibit moderate 
antibacterial properties against Salmonella typhosa. Salmonella montevideo, Salmonella 
schottmuelleri, Shigella paradys, BH and Shigella paradys, III-Z. Leach demonstrated that 
acetone extracts obtained from Cycas circinalis, M. citrifolia, Bridelia penangiana, Tridax 
Procumbens, Hibiscus tiliaceus, and Hypericum papuanun show antibacterial activity. The 
widespread medicinal use of these plants would suggest that they do contain 
pharmacologically active substances, and alternative methods of extraction and screening 
should be utilised to find the major bioactive component in the plants for the purpose of 
new drug development. Locher reported that selected plants including M. citrifolia have a 
history of use in Polynesian traditional medicine for the treatment of infectious diseases. These 
plants have been investigated for anti-viral, anti-fungal, and anti-bacterial activity in vitro. 
Their study using in vitro biological assays confirmed that some of the Hawaiian medicinal 
plants in ethnobotanical reports have curative properties against infectious diseases.  
Duncan demonstrated that scopoletin, a health promoter in M. citrifolia L., inhibits the 
activity of E. coli, which is associated with recent outbreaks resulting in hundreds of serious 
infections, even death. M. citrifolia L. also helps stomach ulcers by inhibiting H. pylori 
bacteria.  
2.5.2 Antiviral activity 
Umezawa and coworkers found that a compound isolated from M. citrifolia L. roots named 
1-methoxy-2-formyl-3-hydroxyanthraquinone suppresses the cytopathic effect of HIV-
infected MT-4 cells without inhibiting cell growth.  
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2.5.3 Anti-tubercular effects 
At the International Chemical Congress of the Pacific Basin Societies meeting in Honolulu, 
Saludes and colleagues from the Philippines reported that M. citrifolia L. kills 
Mycobacterium tuberculosis. A concentration of extracts from M. citrifolia L. leaves killed 
89% of the bacteria in a test tube, almost as effectively as the leading anti-TB drug 
Rifampicin, which has an inhibitory rate of 97% at the same concentration. Although there 
have been anecdotal reports of native use of M. citrifolia L. in Polynesia as a medicine against 
tuberculosis, this is the first report demonstrating the antimycobacterial potential of 
compounds obtained from M. citrifolia L. leaves. "I hope that pharmaceutical companies will 
pay attention to this research and explore the M. citrifolia L. plant as a potential source of 
drugs", said Saludes in Manila.  
2.5.4 Antitumor activity 
At the 83rd Annual meeting of the American Association for Cancer Research in 1992, 
Hirazumi, a researcher at the University of Hawaii, reported that the alcohol-precipitate of 
M. citrifolia L. fruit juice (noni-ppt) has anticancer activity on lung cancer in C57 B1/6 mice. 
This M. citrifolia L.-ppt was shown to significantly prolong (by up to 75%) the life of mice 
with implanted Lewis lung carcinoma. It was concluded that the M. citrifolia L.-ppt seems to 
suppress tumour growth indirectly by stimulating the immune system. Improved survival 
time and curative effects occurred when M. citrifolia L.-ppt was combined with sub-optimal 
doses of the standard chemotherapeutic agents, such as adriamycin (Adria), cisplatin 
(CDDP), 5-fluorouracil (5-FU) and vincristine (VCR), suggesting that M. citrifolia L.-ppt has 
important clinical utility as a supplemental agent in cancer treatment. These results indicate 
that M. citrifolia L.-ppt may enhance the therapeutic effect of anticancer drugs. Therefore, it 
may be of benefit to cancer patients by enabling them to use lower doses of anti-cancer 
drugs to achieve the same or even better results.  
Dr. Wang and coworkers demonstrated a cytotoxic effect of TNJ on a cultured leukaemia 
cell line at various concentrations. TNJ showed dose-dependent cytotoxicity on cultured 
cancer cells by inducing cancer cell necrosis at high doses and apoptosis at lower doses. 
Synergistic effects of TNJ with known anticancer drugs have been found. At sub-optimal 
doses, both prednisolone and TNJ can induce apoptosis. When the dose of prednisolone is 
fixed and the dose of TNJ increases, apoptotic cells significantly increase. Therefore, TNJ is 
able to enhance the efficacy of anticancer drugs such as prednisolone. When a single dose of 
Taxol induces a lower percentage of apoptosis in leukaemia cells, TNJ enhances the rate of 
apoptosis to 100%. These results indicate that TNJ is able to enhance the therapeutic effects 
of anticancer drugs such as Taxol. These findings regarding the combination of anticancer 
drugs with TNJ may be significant. This approach may allow lower doses of synthetic 
anticancer drugs to be used, increase the tolerance of patients to the toxicity of anticancer 
drugs, and increase immune function, thus creating a new method for treating cancer patients.  
In 1993, Hiramatsu and colleagues reported in Cancer Letters the effects of over 500 extracts 
from tropical plants on K-Ras-NRK cells. Damnacanthal, isolated from M. citrifolia L. roots, 
is an inhibitor of Ras function. The ras oncogene is believed to be associated with signal 
transduction in several human cancers such as lung, colon, and pancreatic cancer and 
leukaemia.  
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Hiwasa and coworkers demonstrated that damnacanthal, an anthraquinone compound 
isolated from the M. citrifolia L. roots, has potent inhibitory activity towards tyrosine kinases 
such as Lck, Src, Lyn and EGF receptors. In his research, he examined the effects of 
damnacanthal on ultraviolet ray-induced apoptosis in ultraviolet-resistant human UVr-1 
cells. Consequently, the ultraviolet light induced a concurrent increase in both 
phosphorylated extracellular signal-regulated kinases and stress-activated protein kinases. 
After pretreatment with damnacanthal, there was a stimulatory effect on ultraviolet-induced 
apoptosis.  
Dong reported that two glycosides extracted from M. citrifolia L.-ppt were effective at 
inhibiting cell transformation induced by TPA or EGF in the mouse epidermal JB6 cell line. 
This inhibition was found to be associated with the inhibitory effects of these compounds on 
AP-1 activity. The compounds also blocked the phosphorylation of c-jun, a substrate of 
JNKs, suggesting that JNKs are a critical target for the compounds in mediating Ap-1 
activity and cell transformation.  
2.5.5 Antihelmintic activity  
An ethanol extract of tender M. citrifolia L. leaves was found to induce paralysis and death 
in the human parasitic nematode Ascaris Lumbricoides within a day. A botanist via Morton 
reported that M. citrifolia L. has been used in the Philippines and Hawaii as an effective 
insecticide.  
2.5.6 Hypotensive activity  
Dang Van Ho of Vietnam demonstrated that total extract of M. citrifolia L. roots has a 
hypotensive effect. Moorthy and coworkers found that an ethanol extract of M. citrifolia L. 
roots lowers blood pressure in anesthetised dogs. Youngken’s research team determined 
that a hot water extract of M. citrifolia L. roots lowers blood pressure in anesthetised dogs. A 
Hawaiian physician reported that M. citrifolia L. fruit juice has a diuretic effect.  
2.5.7 Immunological activity 
Asahina found that an alcohol extract of M. citrifolia L. fruit at various concentrations 
inhibits the production of tumour necrosis factor-alpha (TNF-┙), which is an endogenous 
tumour promoter. Therefore, the alcohol extract may inhibit the tumour promoting effect of 
TNF- ┙. Hirazumi found that M. citrifolia L.-ppt contains a polysaccharide-rich substance 
that inhibits tumour growth. It does not cause significant cytotoxicity in adopted cultures of 
lung cancer cells, but it can activate peritoneal exudate cells to impart profound toxicity 
when co-cultured with tumour cells. This suggests the possibility that M. citrifolia L.-ppt 
may suppress tumour growth through activation of the host immune system. M. citrifolia L.-
ppt is also capable of stimulating the release of several mediators from murine effector cells, 
including TNF- ┙, interleukin-1 beta (IL-1┚), IL-10, IL-12, interferon-gamma (IFN- ┛) and 
nitric oxide (NO). Hokama separated ripe M. citrifolia L. fruit juice into 50% aqueous alcohol 
and precipitate fractions, which was found to stimulate BALB/c thymus cells in 
(3H)thymidine analysis. It has been suggested that inhibition of Lewis lung tumours in mice, 
in part, may be due to the stimulation of the T-cell immune response.  
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Wang and coworkers at the University of Illinois college of Medicine observed that the 
thymus is enlarged in animals treated with TNJ. The wet weight of the thymus was 1.7 times 
that of control animals on the seventh day after receiving 10% TNJ in drinking water. The 
thymus is an important immune organ in the body that generates T cells and is involved in 
the aging process and cellular immune fractions. TNJ may enhance immune function by 
stimulating thymus growth and thereby exerting anti-aging and anticancer activities and 
protecting people from other degenerative diseases.  
2.5.8 Mental health and improved high frequency hearing  
A small human clinical trial of the effects of TNJ on auditory function and quality of life in 
patients with decreased bone mineral density and auditory function was conducted at the 
UIC College of Medicine, Rockford, IL. This study showed that TNJ improves both mental 
health and high frequency hearing. The results suggest that increased amounts or extended 
duration of TNJ intake may be required to influence this disorder.  
2.6 Study of TNJ for cancer prevention  
“To take medicine only when you are sick is like digging a well only when you are thirsty – 
is it not already too late?” (Chi Po, c 2500 B.C.). This proverb suggests that prevention is 
more important than treatment.  
Cancer is the second leading cause of death in the US. According to the American Cancer 
society, 1500 people per day die from cancer in the United States. Fighting against cancer is 
a great task for scientists engaged in this field. The aetiology of most cases of human cancer 
remains unknown. Exposure to environmental carcinogens accounts for more than 90% of 
human cancers. Cigarette smoke is the number one high-risk environmental factor. 
Although some cancers are preventable, a means to prevent most cancers is not yet known. 
Seeking a natural way to prevent human cancer is an urgent task for cancer prevention 
investigators.  
Studies of food, diet, and cancer have indicated that lifestyle changes such as eating more 
fruits and vegetables and quitting smoking will help prevent cancer. ”A new plate” for 
America (75% vegetables, 25% meat) appeared at the 2001 annual conference of the 
American Institute for Cancer Research. Although TNJ possesses a broad range of 
therapeutic effects, its ability to prevent cancer remains unclear. Recently, new hypothesis 
has been investigated: whether or not TNJ can help prevent cancer during the early stages of 
chemical carcinogenesis.  
This hypothesis was examined using two carcinogenic animal models and one human 
clinical study of a group of current smokers. The animal models included the following: the 
DMBA-induced mammary gland tumourigenesis model and an acute liver injury model 
induced by the liver carcinogen carbon tetrachloride (CCl4). These are classical extrinsic 
carcinogenic models. DMBA-induced DNA adduct formation and histological examination 
by light and electron microscopy were used as sensitive biomarkers to evaluate the 
preventive effects of TNJ at the initiation stage of multiple-step carcinogenesis. In the 
mammary breast carcinogenic model, to monitor the mechanisms of carcinogenesis and 
DMBA DNA-adduct formation in mammary tissue, the focus was on the pathogenic 
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changes after DMBA administration. In the acute liver injury model, the histopathological 
changes in liver tissue and levels of both super-oxide anion free radicals (SAR) and lipid 
hydroperoxide (LPO) after CCl4 administration were the focus.  
DMBA DNA-adduct formation was used as a marker to examine whether TNJ is able to 
prevent carcinogen-induced DNA damage. Most chemical carcinogens need to be activated 
by endogenous enzymes to be transformed into a form that readily binds to genetic DNA to 
form DNA-adducts. Carcinogen-DNA adduct formation is an important DNA damage 
marker that predicts the possibility of cancer development. Most scientists agree that 
carcinogen-induced DNA adduct formation is an early critical step in the multiple stages of 
carcinogenesis. Carcinogen-DNA adducts can be repaired by endogenous enzymes. 
Unrepaired adducts are fixed after one cell cycle. Unrepaired DNA damage is responsible 
for mutations and subsequent cancer development. Therefore, preventing carcinogen-DNA 
adduct formation is a key aspect of preventing the initial steps of carcinogenesis. If TNJ can 
prevent and/or block the formation of carcinogen-induced DNA adducts, it may prevent 
cancer at the initiation of multiple-stage carcinogenesis.  
In recent years, increasing demand for higher quality and safer foods and medicines, as well 
as concern for environmental pollution during their commercial production, have triggered 
stringent regulations on toxin levels in foods and medicines as well as on the discharge of 
pollutants to the environment. In addition, there has been increasing consumer preference 
for natural substances. All these factors have provided strong motivation for the development 
of cost-effective new technologies, such as the eco-friendly extraction of natural substances 
employing green and safe solvents. In recent years, supercritical fluid extraction (SFE) has 
emerged as a highly promising environmentally benign technology for the production of 
natural extracts such as flavours, fragrances, spice oils, and oleoresins; natural anti-oxidants; 
natural colours; nutraceuticals and biologically active compounds. The state of a substance 
is called supercritical when both temperature and pressure exceed their critical point values. 
A supercritical fluid combines two beneficial properties, namely high density (which 
imparts high solvent power) and high compressibility (which permits high selectivity due to 
large changes in solvent power in response to small changes in temperature and pressure). 
In addition, SFE offers very attractive extraction characteristics owing to its favourable 
diffusivity, viscosity, surface tension, and other thermo-physical properties.  
Since the 1980s, several potential applications of SFE have been reported. So far, the most 
popular SF has been carbon dioxide (CO2), owing to its easy availability, low cost, 
nonflammability, nontoxicity, and its possession of a wide spectrum of solvent properties. 
Its critical temperature is 31.1 °C and its critical pressure is 73.8 bar. Dense or supercritical 
carbon dioxide could very well be the most commonly used solvent in this century due to its 
wide-ranging applications. Its near-ambient critical temperature makes it ideally suitable for 
processing thermally labile natural substances. It is generally regarded as safe (GRAS), and 
it yields microbial-inactivated, contaminant-free, tailor-made extracts of superior 
organoleptic profile and longer shelf life with highly potent active ingredients. The SFE 
technique ensures high consistency and reliability in the quality and safety of bioactive heat-
sensitive botanical products as it does not alter the delicate balance of bioactivity of natural 
molecules. All of these advantages are almost impossible with conventional processes. 
Therefore, SFE technology using SC-CO2 as the solvent is an ideal alternative to the 
conventional techniques for the extraction of bioactive ingredients from spices. 
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3. Conclusion 
Morinda citrifolia L., commonly known as noni, has a long history of widespread use as a 
food in tropical regions from Indonesia to the Hawaiian Islands, and it is used as an herbal 
remedy for multiple diseases. Its fruit, leaves, seeds, bark and roots have been traditionally 
used for the prevention or improvement of various diseases, including arthritis, infections, 
colds, cancer, and diabetes. It has been found that Morinda citrifolia L., has antioxidant 
potential equivalent or similar to that of synthetic antioxidants, such as BHT and BHA, 
which are currently used as food additives. The antioxidants which are found in Morinda 
citrifolia L., have no side effects, and thus they could replace synthetic antioxidants in the 
food processing industry and have potential for use in preventive medicine. Thus, this fruit 
can be used as an antioxidant additive in the food processing industry. 
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